• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?

作者信息

Alffenaar J-W C, Marais B J, Thomas T A

机构信息

Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW.

Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW, Children´s Hospital Westmead, Sydney, NSW, Australia.

出版信息

Int J Tuberc Lung Dis. 2021 Nov 1;25(11):879-880. doi: 10.5588/ijtld.21.0451.

DOI:10.5588/ijtld.21.0451
PMID:34686227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9811372/
Abstract
摘要

相似文献

1
Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?高剂量是否足以使耐多药结核病患儿达到较高的异烟肼暴露水平？
Int J Tuberc Lung Dis. 2021 Nov 1;25(11):879-880. doi: 10.5588/ijtld.21.0451.
2
Improved Outcomes With High-dose Isoniazid in Multidrug-resistant Tuberculosis Treatment in Haiti.高剂量异烟肼在海地耐多药结核病治疗中的改善结局。
Clin Infect Dis. 2019 Aug 1;69(4):717-719. doi: 10.1093/cid/ciz039.
3
Isoniazid resistant TB and non-compliance.耐异烟肼结核病与不依从性。
Thorax. 2004 Dec;59(12):1098; author reply 1098-9.
4
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB.高剂量异烟肼在耐多药结核病患儿中的药代动力学。
Int J Tuberc Lung Dis. 2021 Nov 1;25(11):896-902. doi: 10.5588/ijtld.20.0870.
5
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.儿童耐多药结核病的治疗和结局：系统评价和个体患者数据荟萃分析。
PLoS Med. 2018 Jul 11;15(7):e1002591. doi: 10.1371/journal.pmed.1002591. eCollection 2018 Jul.
6
A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.高剂量异烟肼辅助治疗耐多药结核病的随机对照试验。
Int J Tuberc Lung Dis. 2008 Sep;12(9):1102; author reply 1102.
7
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.耐多药结核病的标准短程化疗：6个国家的治疗结果
JAMA. 2000 May 17;283(19):2537-45. doi: 10.1001/jama.283.19.2537.
8
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.洛匹那韦利托那韦与一线和二线抗结核药物在治疗耐多药结核病的 HIV 感染儿童中的药代动力学和药物相互作用。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.00420-17. Print 2018 Feb.
9
[Exposure to multiresisant tuberculosis: study and follow-up of nine children].[接触多重耐药结核病：九名儿童的研究与随访]
An Pediatr (Barc). 2008 May;68(5):490-5. doi: 10.1157/13120048.
10
Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?结核病防治项目是否应投资于耐多药结核病（MDR-TB）的二线治疗？
Int J Tuberc Lung Dis. 2001 Dec;5(12):1078-9.

本文引用的文献

1
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB.高剂量异烟肼在耐多药结核病患儿中的药代动力学。
Int J Tuberc Lung Dis. 2021 Nov 1;25(11):896-902. doi: 10.5588/ijtld.20.0870.
2
Saliva-based linezolid monitoring on a mobile UV spectrophotometer.基于唾液的利奈唑胺监测，采用移动紫外分光光度计。
J Antimicrob Chemother. 2021 Jun 18;76(7):1786-1792. doi: 10.1093/jac/dkab075.
3
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India.印度孟买利福平耐药结核病患儿和青少年的新型结核药物。
Int J Tuberc Lung Dis. 2020 Dec 1;24(12):1265-1271. doi: 10.5588/ijtld.20.0165.
4
A mobile microvolume UV/visible light spectrophotometer for the measurement of levofloxacin in saliva.一种用于测量唾液中左氧氟沙星的移动微体积紫外/可见分光光度计。
J Antimicrob Chemother. 2021 Jan 19;76(2):423-429. doi: 10.1093/jac/dkaa420.
5
Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens.鉴定异烟肼耐药标志物，以指导将高剂量异烟肼纳入结核病治疗方案。
Clin Microbiol Infect. 2020 Oct;26(10):1332-1337. doi: 10.1016/j.cmi.2020.07.004. Epub 2020 Jul 9.
6
Determination of Rifampin Concentrations by Urine Colorimetry and Mobile Phone Readout for Personalized Dosing in Tuberculosis Treatment.尿液比色法和手机读数测定利福平浓度用于结核病治疗的个体化给药。
J Pediatric Infect Dis Soc. 2021 Mar 26;10(2):104-111. doi: 10.1093/jpids/piaa024.
7
European guidance on drug-resistant tuberculosis in children and adolescents.欧洲儿童和青少年耐多药结核病指南。
Lancet Child Adolesc Health. 2020 Jan;4(1):9-11. doi: 10.1016/S2352-4642(19)30332-3. Epub 2019 Oct 30.
8
Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs.儿童耐多药结核病感染与疾病：新型及重新利用药物综述
Ther Adv Infect Dis. 2019 Jul 19;6:2049936119864737. doi: 10.1177/2049936119864737. eCollection 2019 Jan-Dec.
9
Alternative dosing guidelines to improve outcomes in childhood tuberculosis: a mathematical modelling study.改善儿童结核病结局的替代剂量指南：一项数学建模研究。
Lancet Child Adolesc Health. 2019 Sep;3(9):636-645. doi: 10.1016/S2352-4642(19)30196-8. Epub 2019 Jul 16.
10
Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.坦桑尼亚农村地区儿童结核病一线药物的药代动力学。
J Pediatric Infect Dis Soc. 2020 Feb 28;9(1):14-20. doi: 10.1093/jpids/piy106.